HANSEN GWENN (Chief Scientific Officer) sold 3.1% of their position (3.85K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $90.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.75K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.86K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+3.57K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−3.85K
Price / share
$23.38
Trade value
$89.95K
% of position
Net shares
+6.33K
Net value
-$89.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +3.75K | — | — | 3.3% | 115K | 118.75K |
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +2.86K | — | — | 2.4% | 118.75K | 121.61K |
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +3.57K | — | — | 2.9% | 121.61K | 125.19K |
| Common Stock Direct | 7/30/2026 | S · Sale | −3.85K | $23.38 | $89.95K | 3.1% | 125.19K | 121.34K |
| Total | +6.33K | -$89.95K | ||||||
Restricted Stock Units
Common Stock
3.75K shares
Shares
−3.75K
Strike price
0
Held after
11.25K
Exercisable
—
Restricted Stock Units
Common Stock
2.86K shares
Shares
−2.86K
Strike price
0
Held after
20.01K
Exercisable
—
Restricted Stock Units
Common Stock
3.57K shares
Shares
−3.57K
Strike price
0
Held after
39.30K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 7/30/2026 | M · Option Exercise | −3.75K | 0 | — | 11.25K |
| Restricted Stock Units Direct | Common Stock2.86K shares | 7/30/2026 | M · Option Exercise | −2.86K | 0 | — | 20.01K |
| Restricted Stock Units Direct | Common Stock3.57K shares | 7/30/2026 | M · Option Exercise | −3.57K | 0 | — | 39.30K |